DatasetName,EIF4G2_S(12) EIF4G2_S(393) EIF4G2_S(394) EIF4G2_S(395) EIF4G2_S(398) EIF4G2_S(479) EIF4G2_T(13) EIF4G2_T(19) EIF4G2_T(42) EIF4G2_T(505) EIF4G2_T(507) EIF4G2_T(508),EIF4G2_S(16) EIF4G2_S(17) EIF4G2_S(2) EIF4G2_S(22) EIF4G2_S(454) EIF4G2_T(3) EIF4G2_T(393) EIF4G2_T(470) EIF4G2_T(506) EIF4G2_T(514) EIF4G2_Y(439)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,0.590961051661607,
FSO2013_Ratio M/L normalized Rep3,0.5875382648545552,0.456241498539605
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.5983739804645106,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.6121083637857719,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.5886693607070833,
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.605642013902787,0.4586778746522075
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.6032941117996045,0.44626115756986356
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.5885565594440924,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,0.6053916524162798,0.45836465817278677
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,0.593123920991813,
RB2022_5_PreEndurance,0.600843500191944,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,,0.43277069579442135
WZ2023_Pu_010_30min,0.6383146025317868,0.4327399886185568
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,0.5932249259020189,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.6044376722884511,0.44704457948918214
RB2022_8_RecoveryEndurance,0.5987964782706603,
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.6321490470405361,0.4363568649278459
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,0.5974789614512493,
RB2022_5_PreSprint,0.60332156756303,
PG2020_Intensity 8h_C,0.5940550860496051,
AH2018_SILAC_MR_2_N,0.5950948859355738,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.5947992639190275,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,0.6053631137867491,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,,0.42645545353365777
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,0.6003055357721231,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,0.5821641901604003,
GF2025_P6_Sph,0.5920777421276578,0.44156598649153234
RB2022_2_PreSprint,0.6005896016262904,
ZX2022_CB treated Replicate 3,0.5883700490264122,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.6368577690400861,0.4327560273548369
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,0.5847644897748919,
WZ2023_Pu_005_10min,0.6396680878595579,0.43327662429328856
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.6066246159977249,0.4339123623630814
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.6333284369427278,0.42166982162716005
AH2018_SILAC_MR_2_X,0.6080360227075424,
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,0.5801154879997187,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.5984961975052577,0.4465444301199447
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,0.593336070568216,
EJN2021_3_Rest_Basal,0.6039781394749321,
CR2017_Ratio Replicate 1.3,0.6139402937486955,0.4626945012157233
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.6016888462290735,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,0.5938305915876333,0.4402579800888386
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,0.5913710959069834,0.4315372030217596
AH2018_LFQ_1_C,0.6088916764457177,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.6357522887103446,0.43530851575836615
CK2022_11 40-1,0.6063591380633343,0.4349381790801793
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.6014961482927914,0.44042686401285586
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.5919043938906058,0.43193979992578924
FSO2013_Ratio H/L normalized Rep2,0.6067106824538072,0.4399817054838639
WZ2023_Pu_005_20min,0.6363876007493526,0.42944072564860714
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.619413476858015,0.4548483412026322
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.610361248514859,0.4462966281969699
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,0.614623124578664,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.6045455029378844,
CK2022_1 200-1,0.6058283308552566,
PG2020_Intensity Mock_10h_D,0.6024916185474317,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,0.6065850915726185,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,,0.4413019628622985
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.6126219954665716,
PG2020_Intensity 2h_C,0.5934112920858904,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.5857350180697792,
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,0.5929729881112816,0.43598228612657836
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,0.6088413645307825,0.4531455401232734
CK2022_3 40-1,0.6137674039805007,0.44629670648514297
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,,
HH2022_Reporter intensity 8,,
ZQ2022_N2,0.5921256915795223,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.594568684075755,0.4552810599009245
EJN2021_5_Rest_Basal,0.6009089342764582,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.6000460432597214,
YA2020_Reporter_intensity_Normal_No.1,,
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,0.5793633105413318,
RB2022_1_PostEndurance,0.5927611337214117,
CR2017_Ratio Replicate 3,0.5760365938762813,0.4468274296777332
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,0.5995308976552809,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.5878989749490989,0.44009041800317394
HS2024_8_I_T3,,
CF2017_EOC 3,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,0.6025575405583963,
WZ2023_Pu_010_20min,0.6380690145328259,0.4304371744009367
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.6140787057862755,0.4471168906482099
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.5983273614283945,
KS2014_Intensity N3,0.622915691446555,0.41655604887478764
RB2022_4_RecoveryEndurance,0.6084518692760608,
RB2022_5_RecoveryEndurance,0.606258687933365,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.610496361508217,
FSO2013_Ratio H/M normalized Rep2,0.5598042249767489,0.43935169922841144
RAM2015_Log2 A,0.5913205293363972,0.41826899413518315
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,0.5855159544086721,
KS2014_Intensity E15_2,0.5913991309766131,0.40588120583643106
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.5989187799256896,
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,0.6022323819223666,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.5980748854986347,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,0.5798747718371272,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,,0.43284057068407855
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,0.5874316601959922,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.43235096328081524
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,0.6028199900196859,
AH2018_SILAC_IT_3_X,,0.4334458991794392
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,0.5922752288380558,
FSO2013_Ratio M/L normalized Rep2,0.5982968270284305,0.46683582524564576
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,0.4275881167498032
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,0.606853212318548,0.4335254156714016
RB2022_6_PreSprint,0.6088177583324356,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.5932102232023686,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.6028125157604111,
DL2023_control-1,,
AR2021_ALG 10 μM,0.594885487123212,0.4583111086684829
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,0.44667922457800446
EJN2021_4_Rest_Ins,0.6065770381015814,
RN2012_H05,0.5908555567662833,0.4391373300324928
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.5985614910919431,0.45543941636258867
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,0.591280743579428,
EJN2021_1_Rest_Ins,0.6043509411498467,
HH2022_Reporter intensity 3,0.6044141059016959,0.4446234299607152
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,0.44763087519445255
JW2021_After_3,,
GF2025_P8_Sph,0.5975545672909258,0.45727696970078174
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,0.5996690899545176,0.43916169445565684
CK2022_11 200-1,0.5969423107591273,
CK2022_12 200-1,0.600261618983549,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.6061584391664193,0.46195704108815433
WZ2023_Su_010_20min,0.6352085623909699,0.433832354101084
AH2018_TMTMS2_2_N,0.6326291516352368,0.43826968523618004
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.5903761847424429,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.44747193347675174
AH2018_TMTMS3_Pool,0.596384788177569,0.4534859012497256
KS2014_Intensity N4,0.622323322595549,0.428535334184153
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,0.6116257024157187,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,
CK2022_14 200-1,0.5974522271225902,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,0.5983642380708017,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.5956442160636513,0.4524667824555307
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,0.5983259354368476,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,0.6049711625422591,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.593840121028192,
GF2025_P1_Adh,0.5973650461706342,0.44645600292319026
GF2025_P1_Sph,0.6122055454581133,0.45503572778002827
EJN2021_5_Ex_Basal,0.6025681668556808,
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.6411379470224913,0.4397432565240777
CF2017_EOC 1,0.5926508464161215,
CK2022_3 200-1,0.6067586179490724,
AH2018_LFQ_IT_3_C,0.6027069999707789,0.43578188644787913
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,0.6008229462181248,
CK2022_2 40-1,0.6137075961012717,0.44622490909832685
RB2022_1_PostSprint,0.6064313424308215,
CK2022_4 200-1,0.6058704639992667,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.5977535222036684,
AR2021_ALG 1 μM,0.5929963300274294,0.44208594017467634
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,0.5999318804647373,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,0.6107047594238815,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.5956883833303419,0.4466523829295999
CK2022_9 16-1,0.592980361618786,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.5972309866256948,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.5944818931868177,
CK2022_16 16-1,0.5944822665989989,
FS2019_db/db3,0.6013958057115071,
CK2022_15 40-1,0.6059342881581423,0.43128597174070554
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.6332147098041173,0.42965926614944117
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.5880351983424225,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.6014536877375202,0.44036775029554676
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,0.5950425845342263,0.4569910297914595
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,0.6028895856118829,0.43457511853850106
KBE2022_Log2_Ex_27_U,0.5884236549042606,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.6105052885206399,0.4372078481421237
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,0.578367034230535,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,0.6040796167430676,
YA2020_Reporter_intensity_Normal_No.4,,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.5977110132712081,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.5970669751998007,
RN2012_L13,0.5609878232999724,0.4368932711145126
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.5630181763187962,0.44080331789603294
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.6055252406163883,0.43450100807217973
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.5912458349985956,
HH2022_Reporter intensity 6,0.5917182437385041,0.4441343150154152
RB2022_2_RecoveryStrength,0.6091212152924833,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.6010226288632577,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.6301235529982953,0.43684380735116335
GF2025_P3_Adh,0.5900607793122844,0.43818112171690404
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.6360007896466976,0.43346678221268353
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.5814402999958201,
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,0.5731065726784031,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,0.4463322437207662
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.5981148182563273,0.46677852391054664
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,0.6109570436503055,
RB2022_7_RecoverySprint,0.6006738076965507,
YA2020_Reporter_intensity_Normal_No.3,,
HS2024_8_B_T2,,
AH2018_LFQ_1_X,0.6025506305451219,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.6278284686943808,
HH2022_Reporter intensity 1,0.6062613053596264,0.44622666353570123
HH2022_Reporter intensity 2,0.6062137955973489,0.4441403081270265
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,,0.43565436676822406
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,0.5917507324703318,
CR2017_Ratio Replicate 2,0.6122479575332965,0.4471225074242597
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.5931084866984837,0.46267701249872933
AR2021_KD 72h,0.5956120171185005,0.449675156779858
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.5847744318323328,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.5972956706858069,0.4537368499515134
KBE2022_Log2_Ex_9_U,0.5850494223398529,
AH2018_SILAC_M_3_N,0.6003695797581469,
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.600275493797521,
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,0.5929899710632675,
RN2012_L12,0.5953695691011717,0.44585002668111245
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.6016972870948235,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,0.5615106981624123,0.4271946359787981
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.6087105447412503,0.43261012537924787
RB2022_7_RecoveryEndurance,0.6024371485759588,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,0.6056441010441834,
TM2022_S2.12h.B,,
RN2012_L15,0.5922171992520749,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.5920731968226215,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.5868163079004013,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5977077643547831,0.45805807617844146
RB2022_1_PreSprint,0.5961413984163896,
HS2024_4_I_N1,,
CK2022_7 200-1,0.6013562147107723,
CK2022_5 200-1,0.6015654175576939,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,0.6069685944148366,0.4400519677028322
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.6072423159236333,0.45324788537418853
AH2018_SILAC_MR_1_X,0.6021260697937963,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.5864465822433207,
AH2018_SILAC_3_C,0.6016956070115881,
EJN2021_5_Rest_Ins,0.6055908309690765,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.5588320591098063,0.4256896623027977
CK2022_4 16-1,0.603786076571501,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,0.6045859530323505,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.601264330621986,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,0.6262613228830859,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.5936183504281861,
FSO2013_Ratio H/L normalized Rep3,0.6083237244642495,0.45517221398958446
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,0.5843022927944784,
AH2018_SILAC_IT_2_N,,0.44662887761937564
AH2018_SILAC_IT_1_X,,0.42967656128262727
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,0.6055105758376924,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.5787242285070294,0.4370805655015913
WZ2023_Pe_025_20min,0.6341714535311194,0.43540366090898586
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.5969662346834428,0.4428638868659904
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.6325089260773543,0.43887743762426706
RN2012_H06,0.5968892760782387,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.6310328321960129,0.43528615516649166
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,0.6027475930504389,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.5785849018028272,0.43949370528904785
WZ2023_Su_025_10min,0.6381829087101073,0.434783510355639
AH2018_LFQ_IT_4_X,0.6016689138310615,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,0.6092513134482068,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.6324712128743855,0.43521445789626906
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,0.6120177384491262,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,0.604066790164018,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,,0.43087834975692463
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,0.5971621974472927,
KS2014_Intensity,0.6116666389286814,0.44041890577964915
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.5877025217048458,
LY2019_P7+,0.5915494048803055,
EP2017_Untreated R#1 normalized log2 ratio,,0.4720630044667656
RN2012_L10,0.595256164431774,
PG2020_Intensity 4h_C,0.5921015794242696,
EP2017_Mitotic R#3 normalized log2 ratio,,0.449597980604832
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.5868709401059489,
RB2022_8_PostStrength,0.5710795072850646,
AH2018_SILAC_IT_2_X,,0.4330361399486778
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.5978784917625491,0.44196644481709774
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.5974435155592621,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,,0.43996771270404894
GF2025_P9_Sph,0.6131000036016556,0.44865918468698673
CK2022_6 200-1,0.6015149676304866,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.6050017512636958,0.4554956205971997
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,0.6014323344478071,
PG2020_Intensity 2h_D,0.5980550956990207,
EP2017_Untreated R#3 normalized log2 ratio,,0.4676879317727183
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.600188374340262,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.6175243560548287,
RB2022_7_PostEndurance,0.5873096986766043,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,,0.41910554831321584
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.6027221584347747,0.4357564429187264
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,0.5864877926521593,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,0.6033699408722837,
FR2021_Intensity.M,,
RB2022_2_PostSprint,0.6060349366282635,
AH2018_SILAC_MR_3_N,0.6073165863597058,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.5881007131250822,
PG2020_Intensity CT_C,0.5938936878963191,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,0.5999618913334355,
KS2014_Intensity pY_PV4,,0.4539247330636021
KBE2022_Log2_Ex_39_U,,
EP2017_Untreated R#3 log2 ratio,,0.46805805239168485
RB2022_2_PostStrength,0.5875276205094337,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.6011885999624632,
HS2024_8_PD_T2,,
FS2019_Ctr2,0.6034201636875097,
RB2022_6_PreEndurance,0.6032239870102031,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,0.5860547038394183,
CR2017_Ratio Replicate 2.3,0.6210213355102385,0.4589986525688694
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.6077162277319215,0.44944147357370756
YA2020_Reporter_intensity_Normal_No.2,,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,0.5907163405074422,0.41547303398463176
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.5990276915272434,0.45823922620184077
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,0.6035569367163043,
RAM2015_Log2 B,0.5934658193005712,0.4337266884118391
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,0.6031853089263813,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,0.6058779542632501,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,0.5999469294612342,
WZ2023_Su_025_30min,0.6326004253368835,0.4335015543434045
AH2018_LFQ_4_N,0.6057205871348929,
CR2017_Ratio Replicate 1.2,0.5748472065630102,0.43746375964086676
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,0.5969859910435629,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.5909832753955068,0.42104019464927595
AH2018_SILAC_M_1_X,0.612799698472682,0.4401399266760259
RB2022_7_PreEndurance,0.5959051377426142,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.590274846516582,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.5999790823847643,0.4504566186901562
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,0.6001925936973652,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.5936404123383943,0.4531364373106333
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,0.6044369413671493,
KS2014_Intensity C5,0.5934538138407839,0.44157192393207884
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,0.6087305288788086,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.587372427538778,0.4413503332212404
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.607394184491092,0.45649818577991136
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.5934431928871972,
AH2018_LFQ_2_X,0.6072738168193058,0.45248591433079904
PG2020_Intensity 2h_B,0.5956243522377584,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,0.5988926848486155,
KS2014_Intensity E15_3,0.5946019921920117,0.425442218612339
GF2025_P3_Sph,0.5976705620313568,0.4358411253803193
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.6120763516142839,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,0.4416582484225422
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,0.446634985975437
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,0.6096796808200753,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.6162828926344873,
ZQ2022_N1,0.5963501277177317,
LY2019_P6-,0.5938588395613026,
RM2024_Intensity D2-3,,
UK2020_HCM_1,0.60468514840217,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.5913759326354702,
AH2018_LFQ_3_N,0.6028609116016509,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,0.6032932423547394,
UK2020_UA_1,0.6056104401782646,
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,0.5903350291259449,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,0.6094026661694913,0.431210137298762
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.5964282943851072,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.6332940984890133,0.4298979834756871
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.5963095196337226,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.5901909235622146,0.4299514493557428
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,0.606220321813425,0.4335408199494498
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,0.5992174634334292,
PG2020_Intensity 10h_D,0.5886365853900365,
RB2022_8_PreEndurance,0.5871874550886571,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,0.6057658858172134,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,0.6046271410623,
EP2017_Pervanadate R#3 log2 ratio,,0.4267999444534023
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,0.5904176204544079,
AH2018_SILAC_MR_3_C,0.602849437383013,
AH2018_LFQ_M_4_C,0.6047812076375739,0.4339302285071442
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,0.6037414391249085,0.44422338963840724
CK2022_6 40-1,0.609395579488155,0.4339537464516374
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,
LY2019_P3-,0.6003080695787595,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,0.603761616599385,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.6359158369627312,0.4367586848643785
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,0.6030241477465453,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.5874149410701511,
FS2019_Ctr3,0.6016863872171018,
WZ2023_Pu_025_20min,0.6380536852106061,0.433258330211579
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.6011484904370595,0.4447794958238447
RB2022_1_RecoveryStrength,0.6053756072627162,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.6369409246294638,0.44403736607828814
RB2022_4_PreSprint,0.5993757573834737,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.5919710585970608,0.45421180494014896
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,0.607239501395833,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.6125048896834976,0.43854415267915664
LY2019_P8+,0.5854852674619405,
RB2022_2_RecoveryEndurance,0.5980515647306138,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,0.601668978393219,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.444685074607622
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.6001537785260534,0.45192607486798536
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,
LY2019_P2-,0.6014907834960541,
AH2018_LFQ_IT_1_X,0.6127118910981167,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,0.5944030825546789,
WZ2023_Pe_005_20min,0.6363266664508856,0.4412650653149178
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.6132033184873555,0.4457243768378716
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,0.5873479980894434,
AH2018_TMTMS3_3_N,0.5893155399899516,0.45352451680328554
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.6103560430353928,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,,0.450754269565868
KBE2022_Log2_Ex_36_T,0.5880925492324701,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.6325498792252512,0.4313313381856133
KS2014_Intensity C2,0.5928811709793643,0.45780327503232066
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,
CK2022_9 200-1,0.5963355359367882,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.5955087420780895,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,0.605900262566467,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.6241554611060375,
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.5898860120892716,0.42903131986474735
ZQ2022_C3,0.5956788289038916,
EJN2021_3_Rest_Ins,0.6091255574205853,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,,0.47237528429913184
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.6358130607282334,0.4392036961726582
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.6018297692678692,0.4465229523705641
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.598049752957221,0.4383614371603359
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,0.6040750154428519,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,0.5890882757862071,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.6044966955860835,
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,0.600781803401487,0.43826158084566447
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,0.5967876705211824,0.44741062430828066
FR2021_Intensity.B,,
RB2022_3_PreEndurance,0.6035902210697804,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.6391116606365123,0.4364707163307333
KBE2022_Log2_Ex_29_U,0.5870473876575512,
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,0.6090805294294148,0.44450517151326613
AH2018_LFQ_IT_4_N,0.6000270328773077,
CK2022_15 200-1,0.5973982254862382,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,0.5851715795135309,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.5865716355261957,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.6060440047674654,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.6345012824611996,0.4291309659408484
RN2012_H01,0.5856665497108309,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,0.6026673313214613,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,,0.4304237782576779
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,,
KBE2022_Log2_Ex_44_U,0.5866899405439835,
WZ2023_Pe_010_20min,0.6389028378722384,0.43831847334306934
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,0.6037228055764381,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,0.44054665466025694
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.597384097368629,0.46427010211810965
FSO2013_Ratio H/M normalized Rep3___1,0.5932022761157606,0.46243956781295364
AH2018_SILAC_M_3_C,0.6022738939396177,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.593302395676189,0.4370128662463959
AH2018_SILAC_M_2_X,0.5999583296307094,0.4395365992698976
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.632441332176468,0.43634458273879084
PG2020_Intensity 6h_C,0.5935648123499101,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,0.6048049915162926,0.440686017746969
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.6374060162838356,0.4422858507233671
CK2022_15 16-1,0.5938770890474616,
CK2022_3 16-1,0.6044483528381794,
LY2019_P4-,0.5948035245593004,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,0.5912814082293774,0.44725287631522725
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.5885658562900845,0.4399845633154083
CK2022_10 16-1,0.5939894268111416,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,0.4384995367572989
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,0.6051216378501317,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,,0.4414552567916019
EJN2021_2_Ex_Basal,0.6007129746480316,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,
AR2021_L41 10 μM,0.6006900003308854,0.43715078040936356
CF2017_EOC 2,0.5867863888965462,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.6104287994603479,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,0.6048644599101273,
RB2022_7_PreSprint,0.5950843174396188,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,0.5986392937282707,
ZX2022_CB treated Replicate 1,0.5876400844013783,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.6055898310767122,0.44477700110056423
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,0.6028209233285418,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.6315058261502414,0.4371360837194871
AR2021_L41 1 μM,0.5950807903590339,0.43193975765538184
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.6297265827851078,0.43661834434692925
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.5878894257792067,
KS2014_Intensity C4,0.5966313334242107,0.43613055220487945
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.5850758556856603,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.6017202076284534,0.454711496652563
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,0.5835042786946714,
AH2018_SILAC_IT_3_C,,0.4476188992683446
WZ2023_Pu_025_10min,0.6386937925649333,0.4301433996640214
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,0.5875310556308562,0.4560902474739889
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.5899866755594259,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.6348636267948584,0.4386313154649523
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.599625257819854,0.4391278429941821
KS2014_Intensity C6,0.5898425610823437,0.43374506357517234
ZQ2022_N3,0.5930997222604147,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.6080675991770438,0.4353077802146576
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.5905208470581537,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,0.6061268945037389,0.4331714325771404
AH2018_SILAC_IT_2_C,,0.447612706424146
CK2022_5 40-1,0.6101362359770923,0.43337474950350374
AH2018_LFQ_3_X,0.6067629406351954,
UK2020_UA_3,0.6048905652141335,
LY2019_P7-,0.606274928467336,
GF2025_P5_Adh,0.5889738284691762,0.44822522966266765
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,0.6086882613661095,0.45542535079964724
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.620242456903656,0.4537941704245774
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.5942898035535301,
ZQ2022_C1,0.601201290400425,
CR2017_Ratio Replicate 2.1,0.596917237903039,0.445580015040603
PG2020_Intensity CT_B,0.5995071774401673,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.6053831201038937,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,0.4429424153006025
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,0.600697351122747,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,0.5997099831015166,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.6084573051810634,0.4404546143256189
YA2020_Reporter_intensity_Cancer_No.4,,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.6073462965584542,0.44867260639324785
RB2022_2_PreEndurance,0.6049940169265785,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.587514727585645,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,0.5949864387669809,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,0.60365540787936,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,,0.44277284219508384
AH2018_TMTMS2_1_X,0.6277547922922239,0.43599578963115365
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,0.6048184071781626,
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.5892912642412865,
HS2024_4_I_T3,,
AH2018_SILAC_1_X,0.6126276894068918,
PG2020_Intensity 10h_B,0.5895684825448669,
AH2018_TMTMS3_1_X,0.5999168530467807,0.4526467878225361
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.5959234432786512,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,,0.4355001547505721
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.5858351147092631,
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,,0.41975451560043103
AS2011_Ratio H/L Normalized RNAi_2_1,,
